A trial last year of three chromogenic MRSA media and oxacillin resistance screening agar in Nottingham has led to significant improvements in the detection of this nosocomial pathogen. Here, infection control biomedical scientist Ros Montgomery describes the testing process and the advantages gain in patient care.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.